By a cell-based screening of an in-house natural product library, trichorzin HA V, belonging to a peptaibol family, was isolated from a strain of fungus Trichoderma as a calcitonin (CT) agonist. Like CT, trichorzin HA V elevated cAMP levels in T47D cells which endogenously express the human CT receptor. It also stimulated cAMP formation in cells expressing recombinant human CT receptor, but not in those that do not express the receptor, suggesting that it selectively interacts with the CT receptor. In contrast to trichorzin HA V, alamethicin, another well-characterized peptaibol, showed no cAMP-elevating activity at all. These results suggest that, although there was little amino acid sequence similarity between trichorzin HA V and CT, the biological activity of trichorzin HA V can mimic that of CT, acting via the CT receptor.
Calcitonin (CT), a 32-amino acid peptide hormone ( Fig. 1 ) secreted mainly from the thyroid gland in response to an increase in blood calcium levels, plays an important role in maintaining bone homeostasis.
1) The signal transduction of CT is initiated by its binding to the CT receptor, followed by activation of a stimulatory G protein, Gs.
2) Gs in turn induces the activation of adenylyl cyclase to generate a second intracellular messenger molecule, cAMP, which is biologically important in CT actions. 3) To discover novel compounds that increase the intracellular levels of cAMP similarly to CT, we performed a cell-based screening of an in-house natural product library and isolated a series of trichorzins HA, 4) hydrophobic 18-residue peptides belonging to a peptaibol family, from a strain of fungus Trichoderma. One peptide, trichorzin HA V (Fig. 1) , was identified and characterized.
Peptaibols are linear hydrophobic peptides containing a high proportion of a-amino isobutyric acid (Aib) and isovaline (Iva), with an acetylated N-terminus and a C-terminal amino alcohol. 5) Alamethicin 6) is one of the best characterized peptides with a 20-amino acid residue (Fig. 1) . Trichorzins HA were originally isolated as antibiotic peptides with 18 amino acid residues from Trichoderma harzianum in 1995. 4, 7) The six identified trichorzins HA (HA I through VII except for IV) have been shown to be highly similar in amino acid sequence and differ among themselves only at positions 5, 7 and 16. 4, 7) Although a broad range of biological activities of peptaibols, including anti-bacterial and anti-fungal activities have been reported, 8) there is no report that they selectively act on a receptor. In the present study, we will report that trichorzin HA V, but not alamethicin, shows cAMP-elevating activity only in cells expressing the CT receptor.
MATERIALS AND METHODS

Reagents and Cells
Recombinant human CT 9) was produced in Escherichia coli at Suntory. Alamethicin was purchased from Sigma Chemical Co. (U.S.A.). T47D, a human breast carcinoma cell line, 10) and SaOS2, a human osteoblastlike cell line, 11) were purchased from American Type Culture Collection (U.S.A.). SaOS2 cells expressing a large number of human PTH/PTHrP receptors were isolated by limiting dilution from the original cells, and were used as parental cells in this study. The CHO/hCTR and SaOS2/hCTR cell lines expressing recombinant human CT receptors were established at Suntory as described previously. 12) CHO/ pKDEMSS, established by transfection with the vector only, 13) was used as a negative control cell line. Cell Culture T47D cells were maintained in RPMI1640 containing 10% fetal bovine serum (FBS). CHO/hCTR, CHO/pKDEMSS, SaOS2 and SaOS2/hCTR cells were maintained in a-MEM containing 10% FBS.
Purification of Trichorzins HA A series of trichorzins HA were isolated from solid cultures of a strain of fungus Trichoderma (HF182). The strain was grown in a potato dextrose agar (PDA) medium (Nissui, Japan) at 28°C for 3 weeks. The fermentation broth was extracted with acetone and ethyl acetate, then purified by three cycles of silica gel column chromatography and finally separated as four peaks (HF182a-d) by HPLC. One major peak (HF182b) was identified as a trichorzin HA V 7) by spectroscopy ( 1 H-NMR, FAB-MS-MS) (data not shown).
Cyclic AMP Assay cAMP assay was performed as described previously. 12) In brief, cells were cultured to confluence in 96-well plates for 1-3 d. After being washed with Hanks' balanced salt solution containing 0.1% bovine serum albumin, cells were pre-incubated with the same buffer supplemented with 0.5 mM of 1-methyl-3-isobutylxanthine (MIX), 14) a phosphodiesterase inhibitor, at 37°C for 10 min, then incubated with samples at 37°C for 1 h. After removal of the supernatant, the intracellular cAMP was extracted by lysing the cells with 0.1 ml of ice-cold 0.1 N HCl; they were then neutralized with 0.5 N NaOH and measured by radioimmunoassay using a cAMP 
RESULTS
We isolated a series of antibiotic peptides (HF182a-d), trichorzins HA. 4, 7) HF182a was found to be a mixture of trichorzins HA II and III. Three others were shown to be homogenous by spectroscopy and found to be trichorzins HA V, VI and VII (data not shown). When we performed a cellbased cAMP assay with a human breast carcinoma cell line, T47D cells, which endogenously express human CT receptors on the cell surface, 10) trichorzins HA (IIϩIII, V, VI, VII) caused cAMP elevation (data not shown). One major peptide (HF182b), trichorzin HA V (Fig. 1) , was further characterized. As shown in Fig. 2 , trichorzin HA V and human CT stimulated the intracellular cAMP formation in T47D, CHO/hCTR and SaOS2/hCTR cells expressing endogenous and recombinant human CT receptors, respectively. However, they showed no activity in CHO/pKDEMSS or SaOS2 cells, which do not express the CT receptor. Figure 3 shows the effects of trichorzin HA V and alamethicin on cAMP level in CHO/hCTR cells. Trichorzin HA V, like human CT, elevated cAMP in a concentration-dependent manner with approximately a 25-fold increase at the highest concentration. In contrast, alamethicin showed no cAMP-elevating activity at all. The potency of the activity of trichorzin HA V was much lower than that of human CT, because the EC 50 values for trichorzin HA V and human CT were estimated to be approximately 3.1 mM and 0.01 nM, respectively. It should be noted, however, that the maximum response was comparable to that of human CT (compare Fig. 3A and B) .
DISCUSSION
In the present study, we identified an antibiotic peptaibol, trichorzin HA V, which showed cAMP-elevating activities only in cells expressing the CT receptor. CT is known to activate adenylyl cyclase to generate the intracellular second messenger molecule, cAMP, through interaction with the CT receptor.
3) The finding that, like CT, trichorzin HA V stimulated the pathway in cells expressing the CT receptor suggested that it interacts selectively with the CT receptor. On the other hand, alamethicin, another member of the peptaibol family, did not show any cAMP-elevating activity. Thus, the cAMP-elevating activity of trichorzin HA V is not a common feature of the peptaibol family, such as membrane perturbing activity or ionophoric activity, 5, 8) but probably results from selective interaction with the CT receptor. As far as we know, the present study is the first to demonstrate that a particular member within the peptaibol family selectively acts on a receptor. Further detailed studies are certainly needed to clarify which amino acids are responsible for the CT-like activities.
